NEWRONIKA
Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normal daily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS ... Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. ​ Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
NEWRONIKA
Industry:
Bioinformatics Biotechnology Health Care Hospital Medical Device
Founded:
2008-01-01
Address:
Milan, Lombardia, Italy
Country:
Italy
Website Url:
http://www.newronika.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
11.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apache Euro Apache 2.4 Ubuntu
Similar Organizations
Compliant Concept
Compliant Concept is an innovative technologies for care.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Jefferson Health System
Jefferson Health System is a health care company that offers an extended care community for personal health.
P3 Health Partners
P3 Health Partners is a patient-centered, physician-led and population health-focused healthcare company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Innogest Capital
Innogest Capital investment in Series A - Newronika
Indaco Venture Partners
Indaco Venture Partners investment in Series A - Newronika
F3F
F3F investment in Series A - Newronika
Omnes Capital
Omnes Capital investment in Series A - Newronika
Innogest Capital
Innogest Capital investment in Venture Round - Newronika
Laura Iris Ferro
Laura Iris Ferro investment in Venture Round - Newronika
Atlante Ventures
Atlante Ventures investment in Venture Round - Newronika
F3F
F3F investment in Venture Round - Newronika
Atlante Ventures
Atlante Ventures investment in Seed Round - Newronika
Official Site Inspections
http://www.newronika.com Semrush global rank: 5.32 M Semrush visits lastest month: 1.56 K
- Host name: ec2-54-93-67-207.eu-central-1.compute.amazonaws.com
- IP address: 54.93.67.207
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313
More informations about "Newronika"
Newronika - Crunchbase Company Profile & Funding
Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. …See details»
Newronika / About Us
Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. We …See details»
Newronika | EuroQuity
About your organization / profile Newronika is transforming deep brain stimulation (DBS) through its adaptive platform that uses real-time patient data to optimize therapy. Headquartered in …See details»
Newronika - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Seed Round - Newronika . 1: …See details»
Newronika - News, Locations, Executives and Competitors - Usearch
Newronika (www.newronika.com) is the spin-off company of two of the world-leading research institutions in the field of neurology, the Fondazione IRCCS Ca'Grand... Read More. …See details»
Newronika 2025 Company Profile: Valuation, Funding …
Newronika General Information Description. Developer of a neuro-modulation device designed to restore brain and body functioning. The company's therapeutic device uses the retro-activity system to record brain activity and modulate …See details»
Newronika - Overview, News & Similar companies | ZoomInfo.com
Feb 23, 2021 Newronika restores brain and body functions with its innovative technology, translating their deep knowledge on bio-signal decoding into clinical practice with the aim of …See details»
Newronika
Newronika builds innovative neural devices based on its vast knowledge of biosignal decoding About us AlphaDBS. AlphaDBS is a closed-loop brain neuromodulation implant. AlphaDBS …See details»
Newronika - Company Profile - Tracxn
Mar 5, 2025 Newronika has developed a medical device for neurodegenerative diseases. The company has developed a product called AlphaDBS which is a closed-loop deep brain …See details»
Newronika – Global MedTech Players
Newronika builds innovative neural devices based on its vast knowledge of biosignal decoding. Tags. Care & Therapy. Profile. As the spin-off company of two leading research institutions in …See details»
Newronika Company Profile - Office Locations, Competitors ... - Craft
Newronika develops neuromodulation therapies created to restores brain and body functioning. The company's therapies use a retroactivity system to record brain activity and modulate …See details»
Newronika Interview - Italy Life Sciences 2021
Newronika has raised 12 million euros, money invested to begin the pilot study in Europe. For Q1 2022, we are looking at another financing round to help us fund the testing of the system on a …See details»
Milan-based startup Newronika closes €13.6m to accelerate …
Feb 17, 2025 Newronika, a global player in advanced deep brain stimulation (DBS), has closed €13.6 million Series B funding round. The financing was led by new investor, Fondazione …See details»
Newronika Receives Investigational Device Exemption (IDE) from …
MILAN, Feb. 5, 2025 /PRNewswire/ -- Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an Investigational Device …See details»
Newronika Sercures Initial €2 Million in Blended Finance from EIC ...
Milan, January 22, 2024 – Newronika S.P.A – a pioneering Milan-based leader in adaptive deep brain stimulation and brain device interface technology – has achieved a major milestone in its …See details»
Newronika Receives CE Mark Approval for AlphaDBS, Advancing …
1 day ago Newronika, a leader in neuromodulation and adaptive deep brain stimulation (DBS) technology, announced today that it has received CE Mark approval for its AlphaDBS device, …See details»
Newronika Receives CE Mark Approval for AlphaDBS, Advancing
1 day ago MILAN, March 24, 2025 /PRNewswire/ -- Newronika, a leader in neuromodulation and adaptive deep brain stimulation (DBS) technology, announced today that it has received CE …See details»
Newronika announces CE mark for AlphaDBS system
Feb 24, 2021 According to a company press release, Newronika is a spin-off of the world-class neurological research centre Policlinico of Milan and University of Milan in Milan, Italy. …See details»
Newronika S.p.A. - DevelopmentAid
Newronika S.p.A. — Consulting Organization from Italy with 11-50 employees, has experience with European Commission Directorate-General for International Partnerships (EuropeAid …See details»
Newronika's DBS device gains CE Mark approval for Parkinson's
1 day ago With this approval in place, Newronika is focusing on the commercial launch of the device in select European markets this year, thereby aiming to offer an alternative for PD and …See details»